Baker McKenzie advises Cohere on acquisition of Reliant AI
Baker McKenzie has successfully advised Cohere on its acquisition of Reliant AI, a prominent biopharma AI company with operations in Montreal and Berlin. This strategic acquisition allows Cohere to enhance its sovereign enterprise AI offerings within the global biopharma and healthcare sectors. Founded in 2023, Reliant AI specializes in generative AI solutions and automated data analytics tailored for these industries. The founders of Reliant AI will join Cohere, with key roles assigned to Karl Moritz Hermann and Marc G. Bellemare. Cohere plans to integrate Reliant AI’s technology into its ‘North for Pharma’ product, aimed at improving productivity and efficiency in biopharma R&D and clinical development. The acquisition also includes Reliant AI’s customer relationships with major pharmaceutical companies, further solidifying Cohere’s position in the market. The legal team from Baker McKenzie, led by Dr. Tino Marz, provided comprehensive support across various practice areas, including Corporate/M&A, Intellectual Property, and Regulatory matters.